1. Pfizer Global Research and Development, Chesterfield Parkway West, St. Louis, MO 63017, USA;2. Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
Abstract:
Efforts to improve the potency and physical properties of the aminopyridiopyrazinone class of PDE5 inhibitors through modification of the core ring system are described. Five new ring systems are evaluated and features that impart improved potency and improved solubility are delineated.